ロード中...
Imaging biomarker roadmap for cancer studies
Imaging biomarkers (IBs) are integral to the routine management of patients with cancer. IBs used daily in oncology include clinical TNM stage, objective response and left ventricular ejection fraction. Other CT, MRI, PET and ultrasonography biomarkers are used extensively in cancer research and dru...
保存先:
| 出版年: | Nat Rev Clin Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378302/ https://ncbi.nlm.nih.gov/pubmed/27725679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2016.162 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|